Intervention Review

Tamsulosin for benign prostatic hyperplasia

  1. Timothy J Wilt1,*,
  2. Roderick MacDonald1,
  3. Indy Rutks2

Editorial Group: Cochrane Urology Group

Published Online: 7 SEP 2011

Assessed as up-to-date: 19 AUG 2002

DOI: 10.1002/14651858.CD002081.pub2


How to Cite

Wilt TJ, MacDonald R, Rutks I. Tamsulosin for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews 2011, Issue 9. Art. No.: CD002081. DOI: 10.1002/14651858.CD002081.pub2.

Author Information

  1. 1

    VAMC, General Internal Medicine (111-0), Minneapolis, Minnesota, USA

  2. 2

    VAMC, Department of Internal Medicine (111-0), Minneapolis, Minnesota, USA

*Timothy J Wilt, General Internal Medicine (111-0), VAMC, One Veterans Drive, Minneapolis, Minnesota, 55417, USA. Tim.Wilt@med.va.gov.

Publication History

  1. Publication Status: Withdrawn from publication for reasons stated in the review
  2. Published Online: 7 SEP 2011

SEARCH

  1. Current Version

    Tamsulosin for benign prostatic hyperplasia

    Timothy J Wilt, Roderick MacDonald and Indy Rutks

    Version of Record online: 7 SEP 2011 | DOI: 10.1002/14651858.CD002081.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Tamsulosin for benign prostatic hyperplasia

    Timothy Wilt, Roderick MacDonald and Indy Rutks

    Version of Record online: 21 OCT 2002 | DOI: 10.1002/14651858.CD002081